Literature DB >> 12415085

Use of complementary therapies and non-prescribed medication in patients with Parkinson's disease.

P Ferry1, M Johnson, P Wallis.   

Abstract

Patients with Parkinson's disease resort to complementary therapy and non-prescribed medication in the hope of improving their quality of life. In the US 40% of patients with Parkinson's disease reported the use of at least one form of complementary therapy for Parkinson's disease. Data for the UK are limited. A structured questionnaire was administered to consecutive patients attending a Parkinson's disease clinic. Patients were excluded if they were cognitively impaired, if they were living in an institution, or if they declined to take part. The participants were asked about current and previous use of complementary therapy in general and Parkinson's disease in particular and were presented with an extensive list of complementary therapies and non-prescribed medications. The response rate was 90% and 80 patients met the inclusion criteria. Fifty four per cent (n=44) reported the use of at least one form of complementary therapy or non-prescribed medication either for Parkinson's disease or for some other indication, of whom 31 (38.7% of the total sample) used it solely for the treatment of Parkinson's disease. The most commonly used complementary therapies for Parkinson's disease were massage (n=9) and aromatherapy (n=8). Non-prescribed medication was mainly used for indications other than Parkinson's disease and the commonest drugs used were simple analgesics (n=7), cod liver oil (n=5), and multivitamins (n=4). The use of complementary therapy for Parkinson's disease correlated significantly (Pearson's r=0.44, p=0.01) with a younger age at diagnosis of Parkinson's disease. Comorbidity correlated significantly with complementary therapy use for indications other than Parkinson's disease (Pearson's r=0.29, p= 0.01). The use of complementary therapy for Parkinson's disease in this UK based clinic closely mimics that in the US. Non-pharmacological complementary therapy is mainly used for Parkinson's disease, while non-prescribed medication is more commonly used for other indications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12415085      PMCID: PMC1742510          DOI: 10.1136/pmj.78.924.612

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  8 in total

1.  The BBC survey of complementary medicine use in the UK.

Authors:  E Ernst; A White
Journal:  Complement Ther Med       Date:  2000-03       Impact factor: 2.446

2.  Alternative medicine--the risks of untested and unregulated remedies.

Authors:  M Angell; J P Kassirer
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

3.  Smoking status, reading level, and knowledge of tobacco effects among low-income pregnant women.

Authors:  C L Arnold; T C Davis; H J Berkel; R H Jackson; I Nandy; S London
Journal:  Prev Med       Date:  2001-04       Impact factor: 4.018

4.  Evaluation of a mental test score for assessment of mental impairment in the elderly.

Authors:  H M Hodkinson
Journal:  Age Ageing       Date:  1972-11       Impact factor: 10.668

5.  The use of alternative therapies by patients with Parkinson's disease.

Authors:  P R Rajendran; R E Thompson; S G Reich
Journal:  Neurology       Date:  2001-09-11       Impact factor: 9.910

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Psychosocial factors associated with complementary treatment use in fibromyalgia.

Authors:  P M Nicassio; C Schuman; J Kim; A Cordova; M H Weisman
Journal:  J Rheumatol       Date:  1997-10       Impact factor: 4.666

8.  Alternative therapy use in neurologic diseases: use in brain tumor patients.

Authors:  M J Verhoef; N Hagen; G Pelletier; P Forsyth
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

  8 in total
  13 in total

Review 1.  Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives.

Authors:  Nicolette Perry; Elaine Perry
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Complementary and alternative medicine in Parkinson's disease patients in Korea.

Authors:  Ji-Young Kim; Beom S Jeon
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

Review 3.  Management of pain in Parkinson's disease.

Authors:  Munazza Sophie; Blair Ford
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

4.  Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance.

Authors:  Seung-Nam Kim; Ah-Reum Doo; Ji-Yeun Park; Hyunwoo J Choo; Insop Shim; Jongbae J Park; Younbyoung Chae; Bena Lee; Hyejung Lee; Hi-Joon Park
Journal:  Brain Res       Date:  2013-12-07       Impact factor: 3.252

Review 5.  Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys.

Authors:  Paul Posadzki; Leala K Watson; Amani Alotaibi; Edzard Ernst
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

6.  Initiation of treatment in early PD (evidences based).

Authors: 
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

7.  In vitro neuroprotective potential of four medicinal plants against rotenone-induced toxicity in SH-SY5Y neuroblastoma cells.

Authors:  Keabetswe Seoposengwe; Jacob John van Tonder; Vanessa Steenkamp
Journal:  BMC Complement Altern Med       Date:  2013-12-12       Impact factor: 3.659

8.  Nationwide Survey of Patient Knowledge and Attitudes towards Human Experimentation Using Stem Cells or Bee Venom Acupuncture for Parkinson's Disease.

Authors:  Sun Ju Chung; Seong Beom Koh; Young-Su Ju; Jae Woo Kim
Journal:  J Mov Disord       Date:  2014-10-30

Review 9.  Professional ethics in complementary and alternative medicines in management of Parkinson's disease.

Authors:  Hee Jin Kim; Beomseok Jeon; Sun Ju Chung
Journal:  J Parkinsons Dis       Date:  2016-10-19       Impact factor: 5.568

10.  Complementary and alternative medicine in Indian Parkinson's disease patients.

Authors:  Awadh Kishor Pandit; Deepti Vibha; Achal Kumar Srivastava; Garima Shukla; Vinay Goyal; Madhuri Behari
Journal:  J Tradit Complement Med       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.